Study Demonstrates Safety and Reliability of Checkpoint Nerve Stimulator/Locator for Neural Monitoring in Thyroid Surgery

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190529005651/en/

Scan the QR code to read the abstract and access the full article. (Graphic: Business Wire)

“This is a very gratifying event for Checkpoint Surgical,” said President and CEO Len Cosentino. “We’ve always known from the reports of the surgeons who use our nerve stimulation technology that it provides safe, reliable and repeatable information for nerve assessment and protection during surgery. But the validation provided in this study is extremely meaningful to our clinical value proposition.” Cosentino continued: “Our objective is to give surgeons an easier, more cost-effective alternative to monitor nerves intraoperatively that is also safe and clinically effective. This study adds to our confidence that we are meeting our objective.”

About Checkpoint Surgical, Inc.

Checkpoint Surgical is a privately held, Cleveland, Ohio-based medical device company committed to providing surgeons with user-friendly, cost-effective devices to protect and repair nerves intraoperatively across the anatomy. At Checkpoint Surgical, our mission is to advance the science and practice of nerve protection and repair to improve the quality of life for patients and physicians. For more information regarding Checkpoint please visit www.checkpointsurgical.com

To read the abstract and access the full article, visit https://www.ncbi.nlm.nih.gov/pubmed/31022318.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190529005651/en/